A 34-year-old man with HIV has been taking dolutegravir-rilpivirine antiretroviral therapy for approximately 1 year with sustained suppression of HIV RNA levels; the most recent CD4 count was 724 cells/mm3. He has no other medical problems. He transfers his care to a new clinic, and on review of his immunization status, he states he has never received the hepatitis B vaccine. Laboratory studies are obtained that show:
- Negative hepatitis B surface antigen (HBsAg
- Negative hepatitis B surface antibody (HBsAb)
- Positive hepatitis B core antibody (anti-HBc total)
After reviewing the hepatitis B serologic studies, which one of the following should be recommended as the next step?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
May 13th, 2025
May 13th, 2025
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5